Listed

Medicus Pharma Ltd.

MDCXNasdaqCIK 1997296HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$11.5m, Q2 FY2026
Net income−$11.6m, Q2 FY2026
Line itemUnitperiod not labelled2024-03-31period not labelled2024-06-30period not labelled2024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m0.3Research and development, period not labelled, three months to 2024-03-31$321.4k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-12, accession 0001062993-25-009125.Report this figure1.3Research and development, period not labelled, three months to 2024-06-30$1.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-08-11, accession 0001062993-25-014058.Report this figure0.6Research and development, period not labelled, three months to 2024-09-30$564.1k. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figure1.4Research and development, Q4 FY2024, three months to 2024-12-31$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-25, accession 0001062993-26-001606. Derived: 12-month figure less the 9-month figure.Report this figure2.0Research and development, Q1 FY2025, three months to 2025-03-31$2.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure1.4Research and development, Q2 FY2025, three months to 2025-06-30$1.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure1.7Research and development, Q3 FY2025, three months to 2025-09-30$1.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figure2.6Research and development, Q4 FY2025, three months to 2025-12-31$2.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-25, accession 0001062993-26-001606. Derived: 12-month figure less the 9-month figure.Report this figure2.7Research and development, Q1 FY2026, three months to 2026-03-31$2.7m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure4.9Research and development, Q2 FY2026, three months to 2026-06-30$4.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure
Operating income$m(1.7)Operating income, period not labelled, three months to 2024-03-31−$1.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-12, accession 0001062993-25-009125.Report this figure(3.6)Operating income, period not labelled, three months to 2024-06-30−$3.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-08-11, accession 0001062993-25-014058.Report this figure(2.3)Operating income, period not labelled, three months to 2024-09-30−$2.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figure(3.6)Operating income, Q4 FY2024, three months to 2024-12-31−$3.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001062993-26-001606. Derived: 12-month figure less the 9-month figure.Report this figure(5.1)Operating income, Q1 FY2025, three months to 2025-03-31−$5.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure(6.0)Operating income, Q2 FY2025, three months to 2025-06-30−$6.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure(0.0)Operating income, Q3 FY2025, three months to 2025-09-30−$15. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figure(7.8)Operating income, Q4 FY2025, three months to 2025-12-31−$7.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-25, accession 0001062993-26-001606. Derived: 12-month figure less the 9-month figure.Report this figure(8.6)Operating income, Q1 FY2026, three months to 2026-03-31−$8.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure(11.5)Operating income, Q2 FY2026, three months to 2026-06-30−$11.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure
Interest expense$mnot reportednot reportednot reportednot reported0.0Interest expense, Q1 FY2025, three months to 2025-03-31$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure0.0Interest expense, Q2 FY2025, three months to 2025-06-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figurenot reportednot reported0.4Interest expense, Q1 FY2026, three months to 2026-03-31$374.7k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure0.2Interest expense, Q2 FY2026, three months to 2026-06-30$205.6k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure
Net income$m(1.7)Net income, period not labelled, three months to 2024-03-31−$1.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-05-12, accession 0001062993-25-009125.Report this figure(3.6)Net income, period not labelled, three months to 2024-06-30−$3.6m. XBRL concept us-gaap:ProfitLoss. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figure(2.3)Net income, period not labelled, three months to 2024-09-30−$2.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figure(3.5)Net income, Q4 FY2024, three months to 2024-12-31−$3.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001062993-26-001606. Derived: 12-month figure less the 9-month figure.Report this figure(5.1)Net income, Q1 FY2025, three months to 2025-03-31−$5.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure(6.2)Net income, Q2 FY2025, three months to 2025-06-30−$6.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure(20.9)Net income, Q3 FY2025, three months to 2025-09-30−$20.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figure(15.1)Net income, Q4 FY2025, three months to 2025-12-31−$15.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-25, accession 0001062993-26-001606. Derived: 12-month figure less the 9-month figure.Report this figure(9.0)Net income, Q1 FY2026, three months to 2026-03-31−$9.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure(11.6)Net income, Q2 FY2026, three months to 2026-06-30−$11.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure
Diluted EPS$ per share(0.21)Diluted EPS, period not labelled, three months to 2024-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-12, accession 0001062993-25-009125.Report this figure(0.44)Diluted EPS, period not labelled, three months to 2024-06-30−$0.44 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-08-11, accession 0001062993-25-014058.Report this figure(0.24)Diluted EPS, period not labelled, three months to 2024-09-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figurenot reported(0.42)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.42 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure(0.43)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.43 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure(1.12)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$1.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figurenot reported(0.31)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure(0.21)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure
Basic EPS$ per share(0.21)Basic EPS, period not labelled, three months to 2024-03-31−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-12, accession 0001062993-25-009125.Report this figure(0.44)Basic EPS, period not labelled, three months to 2024-06-30−$0.44 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-08-11, accession 0001062993-25-014058.Report this figure(0.24)Basic EPS, period not labelled, three months to 2024-09-30−$0.24 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figurenot reported(0.42)Basic EPS, Q1 FY2025, three months to 2025-03-31−$0.42 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure(0.43)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.43 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure(1.12)Basic EPS, Q3 FY2025, three months to 2025-09-30−$1.12 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figurenot reported(0.31)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.31 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure(0.21)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.21 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure

Balance sheet

Cash and equivalents$15.2m, Q2 FY2026
Shareholders' equity−$1.8m, Q2 FY2026
Line itemUnitperiod not labelled2022-12-31period not labelled2023-12-31period not labelled2024-03-31period not labelled2024-06-30period not labelled2024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reported1.7Cash and equivalents, period not labelled, at 2023-12-31$1.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-03-28, accession 0001062993-25-006485.Report this figurenot reportednot reportednot reported4.2Cash and equivalents, FY2024, at 2024-12-31$4.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-25, accession 0001062993-26-001606.Report this figure4.0Cash and equivalents, Q1 FY2025, at 2025-03-31$4.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-12, accession 0001062993-25-009125.Report this figure9.7Cash and equivalents, Q2 FY2025, at 2025-06-30$9.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-08-11, accession 0001062993-25-014058.Report this figure8.7Cash and equivalents, Q3 FY2025, at 2025-09-30$8.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figure8.7Cash and equivalents, FY2025, at 2025-12-31$8.7m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure6.4Cash and equivalents, Q1 FY2026, at 2026-03-31$6.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure15.2Cash and equivalents, Q2 FY2026, at 2026-06-30$15.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure
Current assets$mnot reported1.9Current assets, period not labelled, at 2023-12-31$1.9m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-03-28, accession 0001062993-25-006485.Report this figurenot reportednot reportednot reported5.4Current assets, FY2024, at 2024-12-31$5.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-25, accession 0001062993-26-001606.Report this figure5.1Current assets, Q1 FY2025, at 2025-03-31$5.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-12, accession 0001062993-25-009125.Report this figure11.0Current assets, Q2 FY2025, at 2025-06-30$11.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-08-11, accession 0001062993-25-014058.Report this figure9.8Current assets, Q3 FY2025, at 2025-09-30$9.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figure9.9Current assets, FY2025, at 2025-12-31$9.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure7.3Current assets, Q1 FY2026, at 2026-03-31$7.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure17.0Current assets, Q2 FY2026, at 2026-06-30$17.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure
Total assets$mnot reported1.9Total assets, period not labelled, at 2023-12-31$1.9m. XBRL concept us-gaap:Assets. 10-K filed 2025-03-28, accession 0001062993-25-006485.Report this figurenot reportednot reportednot reported5.6Total assets, FY2024, at 2024-12-31$5.6m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-25, accession 0001062993-26-001606.Report this figure5.7Total assets, Q1 FY2025, at 2025-03-31$5.7m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-12, accession 0001062993-25-009125.Report this figure11.9Total assets, Q2 FY2025, at 2025-06-30$11.9m. XBRL concept us-gaap:Assets. 10-Q filed 2025-08-11, accession 0001062993-25-014058.Report this figure10.0Total assets, Q3 FY2025, at 2025-09-30$10.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figure10.1Total assets, FY2025, at 2025-12-31$10.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure7.4Total assets, Q1 FY2026, at 2026-03-31$7.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure27.1Total assets, Q2 FY2026, at 2026-06-30$27.1m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure
Current liabilities$mnot reported0.8Current liabilities, period not labelled, at 2023-12-31$781.6k. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-03-28, accession 0001062993-25-006485.Report this figurenot reportednot reportednot reported2.3Current liabilities, FY2024, at 2024-12-31$2.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-25, accession 0001062993-26-001606.Report this figure3.3Current liabilities, Q1 FY2025, at 2025-03-31$3.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-12, accession 0001062993-25-009125.Report this figure8.5Current liabilities, Q2 FY2025, at 2025-06-30$8.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-08-11, accession 0001062993-25-014058.Report this figure10.7Current liabilities, Q3 FY2025, at 2025-09-30$10.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figure9.9Current liabilities, FY2025, at 2025-12-31$9.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure6.0Current liabilities, Q1 FY2026, at 2026-03-31$6.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure10.8Current liabilities, Q2 FY2026, at 2026-06-30$10.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure
Total liabilities$mnot reported0.8Total liabilities, period not labelled, at 2023-12-31$781.6k. XBRL concept us-gaap:Liabilities. 10-K filed 2025-03-28, accession 0001062993-25-006485.Report this figurenot reportednot reportednot reported2.5Total liabilities, FY2024, at 2024-12-31$2.5m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-25, accession 0001062993-26-001606.Report this figure3.5Total liabilities, Q1 FY2025, at 2025-03-31$3.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-12, accession 0001062993-25-009125.Report this figure8.7Total liabilities, Q2 FY2025, at 2025-06-30$8.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-08-11, accession 0001062993-25-014058.Report this figure10.8Total liabilities, Q3 FY2025, at 2025-09-30$10.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figure10.0Total liabilities, FY2025, at 2025-12-31$10.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure6.0Total liabilities, Q1 FY2026, at 2026-03-31$6.0m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure28.8Total liabilities, Q2 FY2026, at 2026-06-30$28.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure
Current portion of debt$mnot reportednot reportednot reportednot reportednot reported0.0Current portion of debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:DebtCurrent. 10-K filed 2026-03-25, accession 0001062993-26-001606.Report this figurenot reported4.7Current portion of debt, Q2 FY2025, at 2025-06-30$4.7m. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2025-08-11, accession 0001062993-25-014058.Report this figure6.8Current portion of debt, Q3 FY2025, at 2025-09-30$6.8m. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figure5.2Current portion of debt, FY2025, at 2025-12-31$5.2m. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure2.3Current portion of debt, Q1 FY2026, at 2026-03-31$2.3m. XBRL concept us-gaap:DebtCurrent. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figurenot reported
Shareholders' equity$m(12.2)Shareholders' equity, period not labelled, at 2022-12-31−$12.2m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-K filed 2025-03-28, accession 0001062993-25-006485.Report this figure1.1Shareholders' equity, period not labelled, at 2023-12-31$1.1m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-K filed 2026-03-25, accession 0001062993-26-001606.Report this figure(0.6)Shareholders' equity, period not labelled, at 2024-03-31−$560.0k. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figure7.1Shareholders' equity, period not labelled, at 2024-06-30$7.1m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figure4.8Shareholders' equity, period not labelled, at 2024-09-30$4.8m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figure3.1Shareholders' equity, FY2024, at 2024-12-31$3.1m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-25, accession 0001062993-26-001606.Report this figure2.1Shareholders' equity, Q1 FY2025, at 2025-03-31$2.1m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure3.2Shareholders' equity, Q2 FY2025, at 2025-06-30$3.2m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure(0.9)Shareholders' equity, Q3 FY2025, at 2025-09-30−$910.1k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figure(0.1)Shareholders' equity, FY2025, at 2025-12-31−$67.6k. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure1.3Shareholders' equity, Q1 FY2026, at 2026-03-31$1.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure(1.8)Shareholders' equity, Q2 FY2026, at 2026-06-30−$1.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure

Cash flow

Operating cash flow−$7.0m, Q2 FY2026
Line itemUnitperiod not labelled2024-03-31period not labelled2024-06-30period not labelled2024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$k(1,177)Operating cash flow, period not labelled, three months to 2024-03-31−$1.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-12, accession 0001062993-25-009125.Report this figure(2,777)Operating cash flow, period not labelled, three months to 2024-06-30−$2.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-08-11, accession 0001062993-25-014058. Derived: 6-month figure less the 3-month figure.Report this figure(3,102)Operating cash flow, period not labelled, three months to 2024-09-30−$3.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001062993-25-016838. Derived: 9-month figure less the 6-month figure.Report this figure(3,192)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$3.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-25, accession 0001062993-26-001606. Derived: 12-month figure less the 9-month figure.Report this figure(3,941)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$3.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure(5,469)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$5.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001062993-26-004230. Derived: 6-month figure less the 3-month figure.Report this figure(6,758)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$6.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-14, accession 0001062993-25-016838. Derived: 9-month figure less the 6-month figure.Report this figure(6,609)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$6.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-25, accession 0001062993-26-001606. Derived: 12-month figure less the 9-month figure.Report this figure(8,970)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$9.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure(6,983)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$7.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-12, accession 0001062993-26-004230. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)55.06m, Q2 FY2026
Line itemUnitperiod not labelled2024-03-31period not labelled2024-06-30period not labelled2024-09-30Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares8.1Diluted shares (weighted), period not labelled, three months to 2024-03-318,076,673 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-05-12, accession 0001062993-25-009125.Report this figure8.2Diluted shares (weighted), period not labelled, three months to 2024-06-308,167,993 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-08-11, accession 0001062993-25-014058.Report this figure9.5Diluted shares (weighted), period not labelled, three months to 2024-09-309,514,738 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figure12.2Diluted shares (weighted), Q1 FY2025, three months to 2025-03-3112,240,437 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure14.3Diluted shares (weighted), Q2 FY2025, three months to 2025-06-3014,284,261 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure18.6Diluted shares (weighted), Q3 FY2025, three months to 2025-09-3018,631,668 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2025-11-14, accession 0001062993-25-016838.Report this figure29.5Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3129,540,833 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001062993-26-002629.Report this figure55.1Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3055,055,225 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure

Shares outstanding: 63.18mShares outstanding, period not labelled, at 2026-08-1063,180,610 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-12, accession 0001062993-26-004230.Report this figure at Aug 10, 2026, from the cover of the 10-Q filed Aug 12, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. Listed shows no prices and gives no investment advice.